Department of Biochemistry, Medical University of Gdansk, Debinki 1 Street, 80-211 Gdansk, Poland.
Department of Cardiac Diagnostics, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.
Int J Mol Sci. 2022 Aug 31;23(17):9886. doi: 10.3390/ijms23179886.
LVAD therapy is an effective rescue in acute and especially chronic cardiac failure. In several scenarios, it provides a platform for regeneration and sustained myocardial recovery. While unloading seems to be a key element, pharmacotherapy may provide powerful tools to enhance effective cardiac regeneration. The synergy between LVAD support and medical agents may ensure satisfying outcomes on cardiomyocyte recovery followed by improved quality and quantity of patient life. This review summarizes the previous and contemporary strategies for combining LVAD with pharmacotherapy and proposes new therapeutic targets. Regulation of metabolic pathways, enhancing mitochondrial biogenesis and function, immunomodulating treatment, and stem-cell therapies represent therapeutic areas that require further experimental and clinical studies on their effectiveness in combination with mechanical unloading.
LVAD 治疗是急性和特别是慢性心力衰竭的有效抢救手段。在多种情况下,它为再生和持续的心肌恢复提供了平台。虽然卸载似乎是一个关键因素,但药物治疗可能提供强大的工具来增强有效的心脏再生。LVAD 支持与药物治疗之间的协同作用可以确保在随后改善患者生活质量和数量的情况下,实现令人满意的心肌细胞恢复效果。本综述总结了之前和当前将 LVAD 与药物治疗相结合的策略,并提出了新的治疗靶点。代谢途径的调节、增强线粒体生物发生和功能、免疫调节治疗以及干细胞治疗是需要进一步进行实验和临床研究的治疗领域,以确定它们与机械卸载相结合的有效性。